wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37538760-639321B8-B638-4442-9033-11014E0F4BAB
Q37538760-639321B8-B638-4442-9033-11014E0F4BAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37538760-639321B8-B638-4442-9033-11014E0F4BAB
Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition.
P2860
Q37538760-639321B8-B638-4442-9033-11014E0F4BAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37538760-639321B8-B638-4442-9033-11014E0F4BAB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00e20e0af8875f846aa4ebc5cfc69ac10c0c74d3
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.